Traitements3programmes
Essais2liés
Publications0liées
SourceDBlocale

Traitements

3
MoléculeIndication / populationPhaseObjectifPaysRésultat
PhenytoinOptic neuritis is caused by inflammation of the optic nerve and causes loss of vision in the affected eye. It is often associated with multiple sclerosis. Loss of vision after an attack of optic neuritis is caused by damage to the nerve fibres in the optic nerve. There are a number of factors that contribute to nerve fibre damage including increased levels of sodium within them, so blocking sodium entry could help to protect them against damage. The purpose of this study is determine whether phenytoin (which blocks sodium entry into cells) can protect against loss of nerve fibres and prevent loss of vision after optic neuritis. Épilepsie, SEP Phase 4 Immunomodulation India À vérifier
PhenytoinOptic neuritis is caused by inflammation of the optic nerve and causes loss of vision in the affected eye. It is often associated with multiple sclerosis. Loss of vision after an attack of optic neuritis is caused by damage to the nerve fibres in the optic nerve. There are a number of factors that contribute to nerve fibre damage including increased levels of sodium within them, so blocking sodium entry could help to protect them against damage. The purpose of this study is determine whether phenytoin (which blocks sodium entry into cells) can protect against loss of nerve fibres and prevent loss of vision after optic neuritis. SEP Phase 2 Neuroprotection + Immunomodulation United Kingdom À vérifier
PhenytoinOptic neuritis is caused by inflammation of the optic nerve and causes loss of vision in the affected eye. It is often associated with multiple sclerosis. Loss of vision after an attack of optic neuritis is caused by damage to the nerve fibres in the optic nerve. There are a number of factors that contribute to nerve fibre damage including increased levels of sodium within them, so blocking sodium entry could help to protect them against damage. The purpose of this study is determine whether phenytoin (which blocks sodium entry into cells) can protect against loss of nerve fibres and prevent loss of vision after optic neuritis. Épilepsie Phase 4 Immunomodulation India À vérifier

Essais cliniques

2
MoléculeIndication / populationPhaseNCTTitreStatut
Phenytoin Épilepsie Phase 4 NCT07072624 Early Post-Traumatic Seizures Prevention Trial (E-PTS Trial) RECRUITING
Phenytoin SEP Phase 2 NCT01451593 Neuroprotection With Phenytoin in Optic Neuritis COMPLETED

Publications

0
MoléculeIndication / populationTitreJournalDate
Aucune publication.